HCM - Hutchison China MediTech Limited Stock Trading

Hutchison China MediTech Limited(NASDAQ: HCM) stock trading, description, contact, officers and directors.

About Hutchison China MediTech Limited

Not available

Stock Information

Hutchison China MediTech Limited Company Name:

HCM Stock Symbol:

NASDAQ Market:

Get HCM Alerts

News, Short Squeeze, Breakout and More Instantly...

HCM - Chi-Med Highlights Savolitinib Clinical Data to be Presented at Virtual WCLC

HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Jan. 14, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (Nasdaq/AIM: HCM) today announces that the final analysis of savolitinib in Phase Ib TATTON study Parts B and D will be presented at the upcoming vi...
HCM - Chi-Med and Inmagene Announce Strategic Partnership to Develop and Commercialize Portfolio of Drug Candidates for Immunological Diseases

HONG KONG, SHANGHAI, China, SAN DIEGO & FLORHAM PARK, N.J., Jan. 10, 2021 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“ Chi-Med ”) (Nasdaq/AIM: HCM) and Inmagene Biopharmaceuticals (“Inmagene”) today announce a strategic partnership to further d...
HCM - Chi-Med Announces the NMPA Approval of Surufatinib (Sulanda® in China) for Non-Pancreatic Neuroendocrine Tumors

– Sulanda ® is Chi-Med’s first oncology drug brought to market without a partnership and the company’s second oncology drug approved in China – – The pivotal Phase III SANET-ep trial demonstrated surufatinib reduced risk of p...